BioPartner UK. (2/2/21). "Press Release: BioPartner Appoints Paul Clewlow as New Advisory Board Member".

	Region	United Kingdom (GB)
	Organisation	BioPartner.co.uk Ltd. (BioPartner UK)
	Organisation 2	Sygnature Discovery Ltd.
	Group	Sygnature Discovery (Group)
	Product	business development (state/region)
	Product 2	BIOTECH
	Person	Clewlow, Paul J. (Sygnature Discovery 202101– Board Member before SVP Business Development)
	Person 2	Goker, Hakan (Merck (DE) 201509 Senior Investment Direcotor MS Ventures before Aescap Venture + Atlas Venture)

BioPartner UK, the trade organisation for internationalising life sciences companies in the UK, has appointed Dr Paul Clewlow to its Advisory Board.

Paul is an experienced Executive and Non-Executive Board level operator with a 30-year track record of success within the pharmaceutical industry and oil industry. Until the end of 2020, Paul was an Executive Director at Sygnature Discovery, an integrated drug discovery and pre-clinical CRO, where he had global responsibility for business development, marketing, and sales activities. His key focus was growing the business internationally, particularly in the USA. Paul has been retained by Sygnature as a Non-Executive Director. He is also on the Board of Sygil Group, a drug discovery company, and was previously a Member of the Supervisory Board of Step Pharma, a Paris-based, venture capital-backed biotech company discovering and developing proprietary treatments for haematological cancers and auto-immune diseases. Paul has a BSc (Hons.) in chemistry from the University of Leicester and was awarded a PhD in synthetic organic chemistry from Cardiff University. He then undertook post-doctoral research at Arizona State University and at the ETH Zürich.

BioPartner works closely with UK bioscience sector stakeholders including regional networks, national trade associations, and government departments; to promote UK expertise and to provide cost-effective access to overseas events, opportunities, and new markets for UK-based organisations. Paul joins Rachel Hemsley, Paul Cronin, Alasdair Stamps, Will Watson, Dave Mead, and Hakan Goker.

Lin Bateson, Chief Executive of BioPartner, said, “We have established a significant UK presence at several international conferences over the past 12 years, and we have created many networking and business opportunities for UK companies. Having such experienced Business Development professionals as Advisors helps to ensure our services to industry are appropriate and the best they can be, particularly as the events and travel industries meet the challenges of the current pandemic by operating in new and innovative ways.”

Ends

For further information contact:

Dr Alasdair Stamps, Chairman
T: +44 20 7193 7815
E: alasdair@biopartner.co.uk

Notes for Editors

About BioPartner UK

BioPartner UK is an independent, accredited trade organisation, promoting international partnering for trade, investment, and collaborations with UK Life Science companies. BioPartner's UK Delegations promote the UK presence at major international biopharma conferences and BioPartner assists companies to attend these events, both virtual and face to face, by providing access to discounted entry fees and support services.

Contact:

Lin Bateson

Email: lin@biopartner.co.uk

Phone: +44 20 7193 7815

Web: www.biopartner.co.uk

Record changed: 2023-06-05

Picture Berlin Partner Voices Uirá Souto Melo Lucid Genomics 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]